Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiation.
Proc Natl Acad Sci U S A
; 115(7): 1582-1587, 2018 02 13.
Article
in En
| MEDLINE
| ID: mdl-29382747
Full text:
1
Database:
MEDLINE
Main subject:
T-Lymphocytes
/
Cell Differentiation
/
Th2 Cells
/
Graft vs Leukemia Effect
/
Janus Kinase 2
/
Primary Myelofibrosis
/
Graft vs Host Disease
Limits:
Animals
Language:
En
Journal:
Proc Natl Acad Sci U S A
Year:
2018
Type:
Article